MedTrace Logo

The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients

NCT03686800 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-03-19

No results posted yet for this study

Summary

This explorative investigation will assess the adhesion and tolerability of the Rivelin® plain patch when applied directly on lesions in subjects with Vulvar Lichen Sclerosus (VLS).

Conditions

  • Vulvar Lichen Sclerosus

Interventions

DEVICE

Rivelin® plain patches

The comfort and adherence of Rivelin® plain patches in Vulva Lichen Sclerosus patients

Sponsors & Collaborators

  • Larix A/S

    collaborator INDUSTRY

  • Dermtreat

    lead INDUSTRY

Principal Investigators

  • Gregor B.E. Jemec, MD · Zealand University Hospital, Dermatology dpt.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-25
Primary Completion
2018-11-15
Completion
2018-11-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686800 on ClinicalTrials.gov